Turmeric, specifically its active compound curcumin, has been studied for its anti-inflammatory and antioxidant properties, which may be relevant to the management of symptoms in Fibromyalgia Syndrome (FMS). While turmeric is commonly used in traditional medicine for a variety of ailments, its application in fibromyalgia is supported by preliminary scientific evidence rather than historical usage.

Several small clinical studies and animal models suggest that curcumin can modulate inflammatory pathways and reduce oxidative stress, both of which are implicated in the pathophysiology of fibromyalgia. For example, some research has shown that curcumin supplementation can reduce overall pain intensity and improve quality of life in chronic pain conditions. However, direct studies specifically investigating turmeric or curcumin in fibromyalgia patients are limited, and most evidence comes from broader chronic pain or inflammatory disease studies.

Systematic reviews and meta-analyses indicate potential benefit, but they also emphasize the need for larger, well-controlled clinical trials specifically targeting fibromyalgia populations. Furthermore, issues of bioavailability and standardized dosing remain unresolved. In summary, while there is a plausible scientific rationale and some early supportive data, the current evidence base is modest, and turmeric cannot be considered a proven therapy for fibromyalgia at this time.